Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-17

FDA Approved: VIBERZI — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for VIBERZI (eluxadoline) submitted by Allergan, Inc. The action concerns the product and its labeling/indication as par…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viberzi (eluxadoline)

Snippet

SUPPL AP for VIBERZI (ELUXADOLINE)